Dr. Lal PathLabs Limited (NSE:LALPATHLAB)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Running Laboratories	27.63B	24.61B	22.27B	20.17B	20.87B
Running Laboratories Growth	12.25%	10.54%	10.40%	-3.38%	32.01%
Total	27.63B	24.61B	22.27B	20.17B	20.87B
Total Growth	12.25%	10.54%	10.40%	-3.38%	32.01%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	27.41B	24.43B	22.01B	19.95B	20.73B
India Growth	12.22%	11.01%	10.32%	-3.79%	31.99%
Outside India	214.45M	183.88M	258.93M	220.22M	139.68M
Outside India Growth	16.62%	-28.98%	17.58%	57.66%	34.28%
Total	27.63B	24.61B	22.27B	20.17B	20.87B
Total Growth	12.25%	10.54%	10.40%	-3.38%	32.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error